Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

Avid Bioservices stock

CDMO
US05368M1062
A2JBKV

Price

11.38
Today +/-
+0.04
Today %
+0.35 %
P

Avid Bioservices stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Avid Bioservices stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Avid Bioservices stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Avid Bioservices stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Avid Bioservices's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Avid Bioservices Stock Price History

DateAvid Bioservices Price
9/30/202411.38 undefined
9/27/202411.34 undefined
9/26/202411.17 undefined
9/25/202410.73 undefined
9/24/202411.61 undefined
9/23/202411.12 undefined
9/20/202411.60 undefined
9/19/202412.45 undefined
9/18/202411.42 undefined
9/17/202411.49 undefined
9/16/202411.29 undefined
9/13/202411.16 undefined
9/12/202411.16 undefined
9/11/202410.60 undefined
9/10/202410.49 undefined
9/9/20248.95 undefined
9/6/20248.83 undefined
9/5/20249.00 undefined
9/4/20249.24 undefined
9/3/20249.73 undefined

Avid Bioservices Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Avid Bioservices, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Avid Bioservices from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Avid Bioservices’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Avid Bioservices. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Avid Bioservices’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Avid Bioservices’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Avid Bioservices’s growth potential.

Avid Bioservices Revenue, EBIT and net profit per share

DateAvid Bioservices RevenueAvid Bioservices EBITAvid Bioservices Net Income
2030e911.47 M undefined0 undefined0 undefined
2029e701.13 M undefined129.71 M undefined0 undefined
2028e539.33 M undefined94.38 M undefined0 undefined
2027e327.17 M undefined120.25 M undefined279.13 M undefined
2027e258.25 M undefined34.86 M undefined0 undefined
2026e202.22 M undefined6.85 M undefined-1.95 M undefined
2025e166.93 M undefined-7.52 M undefined-14.8 M undefined
2024139.91 M undefined-18.68 M undefined-140.75 M undefined
2023149.3 M undefined3.6 M undefined600,000 undefined
2022119.6 M undefined15.4 M undefined127.7 M undefined
202195.9 M undefined12.2 M undefined3.3 M undefined
202059.7 M undefined-10.5 M undefined-15.2 M undefined
201953.6 M undefined-5.6 M undefined-8.9 M undefined
201853.6 M undefined-19.3 M undefined-26.5 M undefined
201757.6 M undefined1.3 M undefined-32.8 M undefined
201644.4 M undefined3.5 M undefined-60.1 M undefined
201526.8 M undefined-50.5 M undefined-54.1 M undefined
201422.4 M undefined-35.7 M undefined-35.8 M undefined
201321.7 M undefined-28.3 M undefined-29.8 M undefined
201215.2 M undefined-42.1 M undefined-42.1 M undefined
201113.5 M undefined-34.7 M undefined-34.2 M undefined
201027.9 M undefined-13.6 M undefined-14.5 M undefined
200918.2 M undefined-16.3 M undefined-16.5 M undefined
20086.1 M undefined-24.1 M undefined-23.2 M undefined
20073.7 M undefined-21.9 M undefined-20.8 M undefined
20063.2 M undefined-19.1 M undefined-17.1 M undefined
20055 M undefined-15.7 M undefined-15.5 M undefined

Avid Bioservices Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)EBIT (M)EBIT MARGIN (%)NET INCOME (M)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
198719881989199019911992199319941995199619971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025e2026e2027e2027e2028e2029e2030e
000000000300001333533618271315212226445753535995119149139166202258327539701911
---------------200.00--66.67-40.00-100.00200.0050.00-51.8515.3840.004.7618.1869.2329.55-7.02-11.3261.0225.2625.21-6.7119.4221.6927.7226.7464.8330.0629.96
---------100.00----100.00100.0033.3333.33---16.6750.0070.3746.1533.3342.8640.9142.3147.7333.33-3.7713.215.0830.5330.2520.815.04-------
00000000030000131100019196599112119-27329363170000000
00-1-2-10-1-2-20-6-11-18-14-10-10-10-12-15-19-21-24-16-13-34-42-28-35-5031-19-5-1012153-18-7634120941290
---------------1,000.00-333.33-333.33-400.00-300.00-633.33-700.00-400.00-88.89-48.15-261.54-280.00-133.33-159.09-192.316.821.75-35.85-9.43-16.9512.6312.612.01-12.95-4.222.9713.1836.7017.4418.40-
00-1-1-10-1-2-6-5-33-15-20-14-9-11-11-14-15-17-20-23-16-14-34-42-29-35-54-60-32-26-8-1531270-140-14-10279000
-------100.00200.00-16.67560.00-54.5533.33-30.00-35.7122.22-27.277.1413.3317.6515.00-30.43-12.50142.8623.53-30.9520.6954.2911.11-46.67-18.75-69.2387.50-120.004,133.33---90.00-92.86-----
0.20.20.20.30.30.30.30.40.50.50.60.91.92.32.733.33.84.14.85.56.36.578.711.917.223.126.130.937.147.15656.359.470.563.863.20000000
---------------------------------------------
Details

Keystats

ⓘ

Revenue and Growth

The Avid Bioservices Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Avid Bioservices is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (k)LONG-T. REC. (M)INTANGIBLE ASSETS (k)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (k)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (M)
198919901991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024
                                                                       
0.70.100.60.1008.112.21.72.44.16.36.13.414.99.817.21615.11019.723.11835.277.56861.446.842.332.436.3169.9126.238.538.11
00000000.100.10.30.100.30.21.50.50.60.80.61.81.51.42.41.71.23.42.57.33.511.711.92525.927.929.01
000000000.400.20000000001.90.30.1000.10.40.40.40.3000000
0.40.30.1000.10.20.10.200.10000.41.20.60.91.92.94.73.15.33.64.35.57.416.233.116.16.610.911.926.143.930.38
0000000000.30.30.70.30.40.30.21.21.51.21.21.72.110.80.71.41.41.42.25.70.70.71.11.92.16.51
1.10.40.10.60.10.10.28.312.82.13.34.96.66.84.317.812.120.219.919.820.126.730.924.841.985.780.681.989.867.951.459.8207.9180.1112.4104
0.70.50.10.10.60.50.42.35.39.31.90.91.10.90.80.91.61.91.82.11.71.52.22.92.72.415.124.32626.525.647.256.1129.8220.1227.67
1001000000000000000000000000000000000000
000000000.40.41.90000000000000000000000000
0000020020020020020000000000000000000000000000
000000000000000000000000000000000000
0.10.10.10.10.2000000.40.20.10.20.30.40.50.71.31.21.31.11.70.60.52.31.82.92.21.51.50.71.6120.1118.54.88
0.90.70.20.20.80.70.62.55.99.94.21.11.21.11.11.32.12.63.13.332.63.93.53.24.716.927.228.22827.147.957.7249.9338.6232.56
21.10.30.80.90.80.810.818.7127.567.87.95.419.114.222.82323.123.129.334.828.345.190.497.5109.111895.978.5107.7265.6430451336.56
                                                                       
5.86.97.27.78.810.817.70000.10.10.10.10.10.10.20.20.20.200.10.10.10.10.20.20.200.10.10.10.10.10.10.06
-0.5-0.5-0.40.30.30.3-0.326.771.97890.5106.6120.3134.2142.3169180204.5224.5246.2248.2275.2311.4347.5391.5470.8512.5559.1591614.8613.6612.9637.5605.8620.2632.7
-4.8-6.5-7.5-7.7-8.8-11.2-18.1-17.8-57.4-72.6-92.7-107.2-116.7-128.4-140-154.4-169.8-186.9-207.7-230.8-247.4-261.9-296-338.1-367.9-403.3-453.6-509.3-537.4-559.1-560.6-571.1-559.9-431.4-430.8-571.87
00000000000-2.3-0.9-0.8-0.30-0.8-0.2000000000000000000
000000000000000000000000000000000000
0.5-0.1-0.70.30.3-0.1-0.78.914.55.4-2.1-2.82.85.12.114.79.617.61715.60.813.415.59.523.767.759.15053.655.853.141.977.7174.5189.560.89
0.40.50.30.30.40.70.10.20.70.70.90.50.71.10.61.31.31.21.72.12.83.443.52.82.410.48.431.94.45.99.39.524.620.67
0000000.90.41.11.31.30.70.71.50.91.11.51.41.823.22.93.74.64.58.38.513.45.12.63.54.210.111.410.16.79
0000000.20.20.30.23.73.83.70.20.81.81.11.41.93.411.35.88.69.613.211.518.435.754.933.415.329.951.554.438.441.66
000000000003.500000000000000000004.40000
0.70.10.3000000.12.50.10.10.10000.20.40.401.51.91.300000000000.50.51.45
1.10.60.60.30.40.71.20.82.24.768.65.22.82.34.24.14.45.87.518.81417.617.720.522.237.357.56337.923.244.470.975.873.670.57
0.40.60.30.30.30.30.3121.93.50.1000.800.40.50.103.21.3000000000.1096.9141.7142.2160.69
0000000000000000000000000000000000072
000000000000000.20.10.10000.20.61.71.10.70.61.11.41.62.22.121.219.937.945.744.34
0.40.60.30.30.30.30.3121.93.50.10010.10.50.50.103.41.91.71.10.70.61.11.41.62.22.221.2116.8179.6187.9205.1
1.51.20.90.60.711.51.84.26.69.58.75.22.83.34.34.64.95.97.522.215.919.318.821.222.838.458.964.640.125.465.6187.7255.4261.5275.67
21.10.20.910.90.810.718.7127.45.987.95.41914.222.522.923.12329.334.828.344.990.597.5108.9118.295.978.5107.5265.4429.9451336.56
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Avid Bioservices provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Avid Bioservices's financial health and stability.

Assets

Avid Bioservices's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Avid Bioservices must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Avid Bioservices after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Avid Bioservices's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (k)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (k)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES ()TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
19891990199119921993199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
-1-1-10-1-2-60-33-11-19-14-9-11-11-14-15-17-20-23-16-14-34-42-29-35-50-55-28-21-4-10111270
00000000001000000000000010112223347
000000000000000000000000000000000-115,0001,000
0000000000300-20010004-2222069-130-61011-16-34
00000050270752012001023658121393-5-2581623
0000000000000000000000000000000001,0001,000
00000000000000000000000000000000000
-1-1000-1-10-4-9-7-9-6-13-10-11-13-16-18-20-10-13-26-35-20-28-36-39-39-25-115319-12
0000000-2-3-2000000-1000000-100-9-9-3-3-1-3-9-56-77
0000000-50-2300000-100000-1-10-2-8-8-304-3-9-56-77
0000000-330300000010000000-1000360000
00000000000000000000000000000000000
0000000100-40-303000004-1-2-1-1000000412100
0000111811191112134238231720025333340733845322611-433
1000111912251181372392317205233132387334412822-2111232
-----------------------------------
00000000000000000000000000-3-4-4-4-4-4-400
000000048-100120-211-57-10-593-51742-9-6-14-4-93133-43-87
-1.91-1.31-0.4-0.3-1.46-1.8-1.49-1.63-7.65-12.72-8.39-9.5-6.47-13.63-10.49-11.66-14.26-17.58-18.7-21.62-10.21-14.17-27.37-37.43-21.78-29.01-45.07-48.91-42.8-29.78-13.12.0221.32-46.94-90.53
00000000000000000000000000000000000

Avid Bioservices stock margins

The Avid Bioservices margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Avid Bioservices. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Avid Bioservices.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Avid Bioservices's sales revenue. A higher gross margin percentage indicates that the Avid Bioservices retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Avid Bioservices's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Avid Bioservices's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Avid Bioservices's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Avid Bioservices. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Avid Bioservices's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Avid Bioservices Margin History

Avid Bioservices Gross marginAvid Bioservices Profit marginAvid Bioservices EBIT marginAvid Bioservices Profit margin
2030e5.23 %0 %0 %
2029e5.23 %18.5 %0 %
2028e5.23 %17.5 %0 %
2027e5.23 %36.75 %85.31 %
2027e5.23 %13.5 %0 %
2026e5.23 %3.39 %-0.97 %
2025e5.23 %-4.51 %-8.87 %
20245.23 %-13.35 %-100.6 %
202321.1 %2.41 %0.4 %
202230.6 %12.88 %106.77 %
202130.55 %12.72 %3.44 %
20206.53 %-17.59 %-25.46 %
201913.43 %-10.45 %-16.6 %
2018-5.41 %-36.01 %-49.44 %
201733.68 %2.26 %-56.94 %
201648.2 %7.88 %-135.36 %
201541.79 %-188.43 %-201.87 %
201441.52 %-159.38 %-159.82 %
201341.94 %-130.41 %-137.33 %
201233.55 %-276.97 %-276.97 %
201145.93 %-257.04 %-253.33 %
201068.82 %-48.75 %-51.97 %
200950 %-89.56 %-90.66 %
200821.31 %-395.08 %-380.33 %
200710.81 %-591.89 %-562.16 %
2006-3.13 %-596.88 %-534.38 %
200512 %-314 %-310 %

Avid Bioservices Stock Sales Revenue, EBIT, Earnings per Share

The Avid Bioservices earnings per share therefore indicates how much revenue Avid Bioservices has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Avid Bioservices earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Avid Bioservices's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Avid Bioservices’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Avid Bioservices's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Avid Bioservices Revenue, EBIT and net profit per share

DateAvid Bioservices Sales per ShareAvid Bioservices EBIT per shareAvid Bioservices Earnings per Share
2030e14.29 undefined0 undefined0 undefined
2029e10.99 undefined0 undefined0 undefined
2028e8.45 undefined0 undefined0 undefined
2027e5.13 undefined0 undefined4.38 undefined
2027e4.05 undefined0 undefined0 undefined
2026e3.17 undefined0 undefined-0.03 undefined
2025e2.62 undefined0 undefined-0.23 undefined
20242.21 undefined-0.3 undefined-2.23 undefined
20232.34 undefined0.06 undefined0.01 undefined
20221.7 undefined0.22 undefined1.81 undefined
20211.61 undefined0.21 undefined0.06 undefined
20201.06 undefined-0.19 undefined-0.27 undefined
20190.96 undefined-0.1 undefined-0.16 undefined
20181.14 undefined-0.41 undefined-0.56 undefined
20171.55 undefined0.04 undefined-0.88 undefined
20161.44 undefined0.11 undefined-1.94 undefined
20151.03 undefined-1.93 undefined-2.07 undefined
20140.97 undefined-1.55 undefined-1.55 undefined
20131.26 undefined-1.65 undefined-1.73 undefined
20121.28 undefined-3.54 undefined-3.54 undefined
20111.55 undefined-3.99 undefined-3.93 undefined
20103.99 undefined-1.94 undefined-2.07 undefined
20092.8 undefined-2.51 undefined-2.54 undefined
20080.97 undefined-3.83 undefined-3.68 undefined
20070.67 undefined-3.98 undefined-3.78 undefined
20060.67 undefined-3.98 undefined-3.56 undefined
20051.22 undefined-3.83 undefined-3.78 undefined

Avid Bioservices business model

Avid Bioservices Inc is a US-based company that specializes in the development and manufacturing of biopharmaceuticals. The company was founded in 1988 and is headquartered in Tustin, California. Since 2018, Avid Bioservices has been a subsidiary of the Japanese company Fujifilm Corporation. Avid Bioservices is one of the most popular companies on Eulerpool.com.

Avid Bioservices Revenue by Segment

  • 3 years

  • 5 years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

Avid Bioservices Revenue by Segment

Segmente202420202019
Manufacturing Revenues119.35 M USD--
Manufacturing Revenue-52.05 M USD43.43 M USD
Process Development Revenues20.57 M USD--
Process Development Revenue-7.66 M USD10.17 M USD

Avid Bioservices SWOT Analysis

Strengths

Weaknesses

Opportunities

Threats

Avid Bioservices Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Avid Bioservices historical P/E ratio, EBIT multiple, and P/S ratio

Avid Bioservices shares outstanding

The number of shares was Avid Bioservices in 2023 — This indicates how many shares 63.8 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Avid Bioservices earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Avid Bioservices's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Avid Bioservices’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Avid Bioservices's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Avid Bioservices stock splits

In Avid Bioservices's history, there have been no stock splits.
Unfortunately, there are currently no price targets and forecasts available for Avid Bioservices.

Avid Bioservices latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
9/30/2024-0.06 -0.03  (46.52 %)2025 Q1
6/30/2024-0.04 -1.94  (-4,965.27 %)2024 Q4
3/31/2024-0.05 -0.09  (-67.91 %)2024 Q3
12/31/2023-0.06 -0.15  (-135.11 %)2024 Q2
9/30/2023-0.03 -0.03  (-6.76 %)2024 Q1
6/30/20230 0  (0 %)2023 Q4
3/31/2023-0.04 0.01  (128.01 %)2023 Q3
12/31/2022-0.01 -0.02  (-292.16 %)2023 Q2
9/30/20220.04 0.02  (-46.52 %)2023 Q1
6/30/20220.01 0.01  (-1.96 %)2022 Q4
1
2
3
4
5
...
7

Eulerpool ESG Scorecard© for the Avid Bioservices stock

Eulerpool World ESG Rating (EESG©)

25/ 100

🌱 Environment

26

👫 Social

35

🏛️ Governance

13

Environment

Scope 1 - Direct Emissions
—
Scope 2 - Indirect emissions from purchased energy
—
Scope 3 - Indirect emissions within the value chain
—
Total CO₂ emissions
—
CO₂ reduction strategy
✅
Coal energy
❌
Nuclear power
❌
Animal experiments
✅
Fur & Leather
—
Pesticides
—
Palm Oil
—
Tobacco
❌
Genetically modified organisms
❌
Climate concept
—
Sustainable forestry
—
Recycling regulations
❌
Environmentally friendly packaging
❌
Hazardous substances
❌
Fuel consumption and efficiency
❌
Water consumption and efficiency
❌

Social

Percentage of female employees—
Percentage of women in management—
Percentage of Asian employees—
Share of Asian management—
Percentage of Hispanic/Latino employees—
Hispano/Latino Management share—
Percentage of Black employees—
Black Management Share—
Percentage of white employees—
White Management Share—
Adult content❌
Alcohol❌
Weapons—
Firearms
❌
Gambling❌
Military contracts❌
Human rights concept❌
Privacy concept—
Occupational health and safety✅
Catholic✅

Governance (Corporate Governance)

Environmental reporting❌
Stakeholder Engagement❌
Call Back Policies❌
Antitrust law❌

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Avid Bioservices shareholders

%
Name
Stocks
Change
Date
7.49881 % State Street Global Advisors (US)4,784,2391,049,17212/31/2023
7.20396 % BlackRock Institutional Trust Company, N.A.4,596,124-4,356,47712/31/2023
6.82171 % T. Rowe Price Investment Management, Inc.4,352,252253,38512/31/2023
6.64600 % Millennium Management LLC4,240,1474,181,06012/31/2023
5.64778 % The Vanguard Group, Inc.3,603,281-809,14912/31/2023
5.26541 % AltraVue Capital, LLC.3,359,332384,9994/15/2024
3.41534 % RBC Global Asset Management (U.S.) Inc.2,178,989585,25312/31/2023
3.23202 % Snyder Capital Management, L.P.2,062,028-168,90312/31/2023
2.78655 % Palisade Capital Management, LLC1,777,821204,98112/31/2023
2.31793 % Wellington Management Company, LLP1,478,842315,60012/31/2023
1
2
3
4
5
...
10

Avid Bioservices Executives and Management Board

Mr. Nicholas Green59
Avid Bioservices President, Chief Executive Officer, Director (since 2020)
Compensation 6.46 M
Mr. Daniel Hart49
Avid Bioservices Chief Financial Officer
Compensation 1.94 M
Mr. Mark Ziebell59
Avid Bioservices Vice President, General Counsel, Corporate Secretary
Compensation 1.38 M
Mr. Matthew Kwietniak54
Avid Bioservices Chief Commercial Officer
Compensation 1.28 M
Mr. Richard Richieri58
Avid Bioservices Chief Operations Officer
Compensation 1.11 M
1
2
3

Avid Bioservices Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
Acumen Pharmaceuticals Stock
Acumen Pharmaceuticals
SupplierCustomer0,940,220,580,90--
Oragenics Stock
Oragenics
SupplierCustomer0,550,850,590,800,50-0,15
Humanigen Stock
Humanigen
SupplierCustomer0,480,880,520,880,30-0,31
Halozyme Therapeutics Stock
Halozyme Therapeutics
SupplierCustomer0,480,10-0,55-0,250,010,51
ADC Therapeutics Stock
ADC Therapeutics
SupplierCustomer0,280,880,640,910,65-0,64
Gilead Sciences Stock
Gilead Sciences
SupplierCustomer0,180,33-0,420,580,440,17
Iovance Biotherapeutics Stock
Iovance Biotherapeutics
SupplierCustomer0,070,72-0,020,680,50-0,50
Coherus BioSciences Stock
Coherus BioSciences
SupplierCustomer-0,110,850,850,950,75-0,36
IGM Biosciences Stock
IGM Biosciences
SupplierCustomer-0,160,74-0,090,820,44-0,09
1

Most common questions regarding Avid Bioservices

What values and corporate philosophy does Avid Bioservices represent?

Avid Bioservices Inc is a company that values innovation, integrity, and reliability. With a corporate philosophy focused on delivering high-quality biologics manufacturing, Avid Bioservices Inc aims to provide efficient and dependable solutions to the biotechnology and pharmaceutical industries. The company prides itself on its commitment to meeting client needs, exceeding expectations, and maintaining strong relationships with its partners. Avid Bioservices Inc's dedication to cutting-edge technologies and compliance with regulatory standards enables them to consistently deliver exceptional, cost-effective services. By upholding these values and corporate philosophy, Avid Bioservices Inc has established itself as a trusted and leading provider in the biopharmaceutical contract development and manufacturing industry.

In which countries and regions is Avid Bioservices primarily present?

Avid Bioservices Inc is primarily present in the United States.

What significant milestones has the company Avid Bioservices achieved?

Avid Bioservices Inc has achieved several significant milestones. The company successfully completed the expansion of its Myford manufacturing facility, which increased its production capacity to meet growing demand. Additionally, Avid Bioservices achieved key regulatory milestones by obtaining FDA approval for multiple biologics produced at its facilities. The company also secured several strategic partnerships and collaborations with renowned pharmaceutical companies, further establishing its position in the market. Furthermore, Avid Bioservices successfully delivered consistent and high-quality manufacturing services, leading to increased customer satisfaction and repeat business. These achievements reflect the company's dedication to innovation, quality, and providing exceptional biomanufacturing solutions.

What is the history and background of the company Avid Bioservices?

Avid Bioservices Inc is a reputable biotechnology company with a rich history and background. Established in 1981, the company has become a leading provider of biomanufacturing services, specializing in the development and production of monoclonal antibodies and recombinant proteins. Avid Bioservices Inc is committed to delivering high-quality, innovative solutions to the biotech industry, serving both large pharmaceutical companies and small biotech firms. With state-of-the-art facilities and a team of experienced scientists, the company has earned a commendable reputation for its expertise in cell culture, process development, and manufacturing. Avid Bioservices Inc consistently strives towards advancing healthcare through its cutting-edge biomanufacturing capabilities.

Who are the main competitors of Avid Bioservices in the market?

The main competitors of Avid Bioservices Inc in the market are Cytovance Biologics, Inc., Lonza Group Ltd., AbbVie Inc., and Catalent, Inc.

In which industries is Avid Bioservices primarily active?

Avid Bioservices Inc is primarily active in the biotechnology and pharmaceutical industries.

What is the business model of Avid Bioservices?

Avid Bioservices Inc is a leading contract development and manufacturing organization (CDMO) that provides comprehensive services for the biotechnology and pharmaceutical industries. The company's business model revolves around offering a wide range of solutions for the development, manufacturing, and commercialization of biologic products. Avid Bioservices specializes in the production of monoclonal antibodies, recombinant proteins, and other biologics. Their state-of-the-art facilities, experienced team, and quality-driven approach enable them to deliver efficient and cost-effective solutions to their clients. With a focus on meeting regulatory requirements and maintaining high standards, Avid Bioservices Inc continues to play a crucial role in supporting biopharmaceutical companies in advancing their therapeutic innovations.

What is the P/E ratio of Avid Bioservices 2024?

The Avid Bioservices P/E ratio is -5.11.

What is the P/S ratio of Avid Bioservices 2024?

The Avid Bioservices P/S ratio is 5.14.

What is the AlleAktien quality score of Avid Bioservices?

The AlleAktien quality score for Avid Bioservices is 4/10.

What is the revenue of Avid Bioservices 2024?

The Avid Bioservices revenue is 139.91 M USD.

How high is the profit of Avid Bioservices 2024?

The Avid Bioservices profit is -140.75 M USD.

What is the business model of Avid Bioservices

Avid Bioservices Inc is a biopharmaceutical company specializing in the development and manufacturing of biopharmaceuticals. The company offers integrated development services and manufacturing services to various customers, including pharmaceutical and biotech companies. The company provides a wide range of services, including manufacturing of clinical batches, scale-up processes, and process optimization. They have a fully integrated GMP production facility in California, USA, and produce both recombinant proteins and monoclonal antibodies. One of the main divisions of Avid Bioservices is the development of cell lines for biopharmaceutical production. They use their expertise in molecular biology to select and develop recombinant cell lines suitable for biopharmaceutical production. They work closely with customers to develop customized cell lines tailored to the requirements of biopharmaceuticals. Another division of Avid Bioservices is the manufacturing of clinical batches of biopharmaceuticals. They have the expertise and capacity to scale production processes and conduct commercial production of biopharmaceuticals. They are capable of producing batches in various sizes, including batches for Phase I, Phase II, and Phase III clinical studies. The company also offers process optimization services to improve the production of biopharmaceuticals. They have extensive experience in transferring production processes from the laboratory to the production scale. They utilize their expertise in process optimization to improve production efficiency and quality, and reduce production costs. The products of Avid Bioservices include a wide range of recombinant proteins and monoclonal antibodies, such as enzymes, hormones, growth factors, antibodies, and other biopharmaceuticals. They work closely with customers to develop customized biopharmaceuticals that meet the specific requirements of diseases. In collaboration with its customers, Avid Bioservices aims to accelerate the clinical development of biopharmaceuticals and expand the available selection of biopharmaceuticals. The company strives to make the production of biopharmaceuticals more efficient, high-quality, and cost-effective. In summary, Avid Bioservices is a biopharmaceutical company specializing in integrated development services and manufacturing services. They offer a wide range of products and services, including the development of cell lines, manufacturing of clinical batches, process optimization, and production of recombinant proteins and monoclonal antibodies. Avid Bioservices aims to accelerate the development of biopharmaceuticals and improve the production of biopharmaceuticals in terms of efficiency, quality, and cost-effectiveness.

What is the Avid Bioservices dividend?

Avid Bioservices pays a dividend of 0 USD distributed over payouts per year.

How often does Avid Bioservices pay dividends?

The dividend cannot currently be calculated for Avid Bioservices or the company does not pay out a dividend.

What is the Avid Bioservices ISIN?

The ISIN of Avid Bioservices is US05368M1062.

What is the Avid Bioservices WKN?

The WKN of Avid Bioservices is A2JBKV.

What is the Avid Bioservices ticker?

The ticker of Avid Bioservices is CDMO.

How much dividend does Avid Bioservices pay?

Over the past 12 months, Avid Bioservices paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Avid Bioservices is expected to pay a dividend of 0 USD.

What is the dividend yield of Avid Bioservices?

The current dividend yield of Avid Bioservices is .

When does Avid Bioservices pay dividends?

Avid Bioservices pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Avid Bioservices?

Avid Bioservices paid dividends every year for the past 0 years.

What is the dividend of Avid Bioservices?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Avid Bioservices located?

Avid Bioservices is assigned to the 'Health' sector.

Wann musste ich die Aktien von Avid Bioservices kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Avid Bioservices from 10/1/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/1/2024.

When did Avid Bioservices pay the last dividend?

The last dividend was paid out on 10/1/2024.

What was the dividend of Avid Bioservices in the year 2023?

In the year 2023, Avid Bioservices distributed 0 USD as dividends.

In which currency does Avid Bioservices pay out the dividend?

The dividends of Avid Bioservices are distributed in USD.

All fundamentals about Avid Bioservices

Our stock analysis for Avid Bioservices Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Avid Bioservices Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.